Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium add-on to Seroquel XR in acute mania
NCT00931723Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Seroquel XR + Lithium with Seroquel XR + Placebo (2 arms). Primary endpoint: Young Mania Rating Scale Total Score at Day 43. Started Jun 2009; status: completed.
02
Drugs
lithium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00931723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931723.